2024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP]

Deadline:N/A

We were not able to find a link to the source, please find contact details in the documents.

Tender information

Grande Lisboa

Type

Contract award

Procedure

Restricted procedure

Ref. number

261Y000083 - B712 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP]

Estimated value

€1,410,776.64

Contract type

Framework agreement

Duration

11 months

AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO]

B712 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP]

BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CÁP/ COMP]

Buyer

Unidade Local de Saúde Santa Maria, E.P.E.

Documents

Document name	Upload date	File size
First document.pdf	1 Jan 1970, 00:00	1 Bytes
Second document.pdf	1 Jan 1970, 00:00	1 Bytes

Information on this page originates from the following sources: TED

Buyer

Unidade Local de Saúde Santa Maria, E.P.E.

Contract awarded

Important dates

27 May - Publication date

Unlock Full Access with Mercell Bidding Business Plus

Start your free trial to explore exclusive features that help you win more tenders, faster:

AI-Powered Tender Insights

Buyer Contact Info

Key Tender Timelines

Already have an account?

We were not able to find a link to the source, please find contact details in the documents.